Beijing Kewei Clinical Diagnostic Reagent INC


Home   >   About Us   >   News   >   KEWEI News   >  

Warmly celebrate the funding of the Nantong EGENS GROUP

      August 31, 2015,EGENS NANTONG witnessed the first general meeting of shareholders, total 24 proposals passed including NANTONG EGENS Corporation establishment Scheme, <<Articles of corporation>>
      Nantong EGENS Corporation sponsored by 33 shareholders, with registered capital of RMB27.1 million,  business covers Class-III6840 IVD reagents , Class-II6840 clinical laboratory analyzer system(with Valid production license), Biotechnology research and transfer; Assembling ,manufacturing and distributing electronic instruments; import & export or provide import or export agent service for varieties of commodities and technology except those banned items. NANTONG EGENS Corporation has 3 wholly owned subsidiary companies,
      EGENS-Beijing( Beijing Kewei Clinical Diagnostic Reagent Inc)
      EGENS-Nantong (Nantong Egens biotechnology Co., Ltd),
      EGENS-Wuxi( Adaltis s.r.l.(China) , a joint venture company established by EGENS & Adaltis (Italy ), providing best product and service in the field of Bio-chemistry, magnetic particles and other varieties of immune reagents.
      EGENS culture: People-oriented, with high senses of care, thanksgiving, responsibility and crisis
      EGENS people: to focus on the best product, service and partnership
      EGENS vision: to create the world leading IVD platform integrating R&D, manufacturing & service as a whole, providing the best products with services innovation, dedicated to the new generation diagnostic products with state-of-the-art technology , serving for people’s quality life

08.31 2015    POST VIEWS: